A Case of Shoulder Desmoid-Type Fibromatosis Missed on an Initial Work Up: Case Report and Literature Review
- 1 College of Medicine, Medical University of South Carolina, Charleston, SC, USA
- 2 Department of Orthopaedics & Physical Medicine, Medical University of South Carolina, Charleston, SC, USA
- 3 Department of Orthopaedics & Physical Medicine, Medical University of South Carolina, Charleston, SC, USA
Abstract
Desmoid-type fibromatosis (DF) is a rare, locally invasive, non-metastasizing soft tissue proliferation derived from mesenchymal progenitor cells. The incidence of DF is 2 to 4 per million per year in the general population and typically affects adults between the ages of 35 - 40. Desmoid-type fibromatosis can either be sporadic or associated with mutation in the adenomatous polyposis coli gene. Trauma, surgery, pregnancy, and oral contraceptives have been identified as risk factors for the development of desmoid-type fibromatosis. MRI is the standard for image characterization, and CT image-guided core needle biopsy for diagnosis. “Wait and see” is the current management recommendation, and studies of y-secretase inhibitors and tyrosine kinase inhibitors have shown promise in the treatment of desmoid-type fibromatosis. This report presents a case of rare right shoulder desmoid type fibromatosis in a 48-year-old male that was missed on an initial workup including EMG/NCS and shoulder MRI, and demonstrates the importance of revisiting the diagnostic process if a former workup has yielded an unclear clinical picture.
- Wu, C., Amini-Nik, S., Nadesan, P., Stanford, W.L. and Alman, B.A. (2010) Aggressive Fibromatosis (Desmoid Tumor) Is Derived from Mesenchymal Progenitor Cells. Cancer Research, 70, 7690-7698. https://doi.org/10.1158/0008-5472.CAN-10-1656
- Skubitz, K.M. (2017) Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor. Mayo Clinic Proceedings, 92, 947-964. https://doi.org/10.1016/j.mayocp.2017.02.012
- Bertario, L., Russo, A., Sala, P., Eboli, M., Giarola, M., D’amico, F., et al. (2001) Genotype and Phenotype Factors as Determinants of Desmoid Tumors in Patients with Familial Adenomatous Polyposis. International Journal of Cancer, 95, 102-107. https://doi.org/10.1002/1097-0215(20010320)95:2 3.0.CO;2-8
- Penel, N., Chibon, F. and Salas, S. (2017) Adult Desmoid Tumors: Biology, Management and Ongoing Trials. Current Opinion in Oncology, 29, 268-274. https://doi.org/10.1097/CCO.0000000000000374
- Penel, N., Coindre, J.M., Bonvalot, S., Italiano, A., Neuville, A., et al. (2016) Management of Desmoid Tumours: A Nationwide Survey of Labelled Reference Centre Networks in France. European Journal of Cancer, 58, 90-96. https://doi.org/10.1016/j.ejca.2016.02.008
- Crago, A.M., Denton, B., Salas, S., Dufresne, A., Mezhir, J., et al. (2013) A Prognostic Nomogram for Prediction of Recurrence in Desmoid Fibromatosis. Annals of Surgery, 258, 347-353. https://doi.org/10.1097/SLA.0b013e31828c8a30
- Wang, Z., Wu, J., Tian, X. and Hao, C. (2019) Targeted Therapy of Desmoid-Type Fibromatosis: Mechanism, Current Situation, and Future Prospects. Frontiers in Medicine, 13, 427-437. https://doi.org/10.1007/s11684-018-0672-6
- Tang, F., Min, L., Yin, R., Zhang, W., Zhou, Y., et al. (2015) Large Desmoid-Type Fibromatosis of the Shoulder Girdle: Operative Approach Selection and Clinic Outcome. International Orthopaedics, 39, 363-369. https://doi.org/10.1007/s00264-014-2660-z
- Stoeckle, E., Coindre, J.M., Longy, M., Binh, M.B., Kantor, G., et al. (2009) A Critical Analysis of Treatment Strategies in Desmoid Tumours: A Review of a Series of 106 Cases. European Journal of Surgical Oncology, 35, 129-134. https://doi.org/10.1016/j.ejso.2008.06.1495
- Bonvalot, S., Eldweny, H., Haddad, V., Rimareix, F., Missenard, G., et al. (2008) Extra-Abdominal Primary Fibromatosis: Aggressive Management Could Be Avoided in a Subgroup of Patients. European Journal of Surgical Oncology, 34, 462-468. https://doi.org/10.1016/j.ejso.2007.06.006